Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by University of Colorado, Denver
The Dana Foundation
Information provided by (Responsible Party):
University of Colorado, Denver Identifier:
First received: August 2, 2011
Last updated: August 4, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)